Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Educ Couns. 2011;83:288‐294.Mitchell B, Armour C, Lee M, et al. Diabetes medi- cation assistance service: the pharmacist's role in sup- ...
Poorly controlled asthma or asthma exacerbations may have a greater fetal/maternal risk than what is associated with appropriately used asthma medications. Maternal treatment improves pregnancy outcomes by reducing the risk of some adverse events (eg, preterm birth, gestational diabetes) (ERS/TSANZ [...
we expanded our eligibility guidelines for financial assistance as we became the secondary payer for many seniors who had Medicare Part D as their primary coverage. However, Medicare Part D introduced major health
doi:10.1001/jamanetworkopen.2024.20724 Key Points Question What happens to out-of-pocket costs for type 2 diabetes (T2D) medications when people with T2D reach age 65 years (when most people enroll in Medicare), and what happens to their utilization of those medications? Findings This cohort ...
Accepted for publication January 17, 2002. This study was supported by grants HL-07427, PE-11001, HL-63841, HL-03533, and CA-87969 from the National Institutes of Health, Bethesda, Md. We thank Karen Corsano, LMS, and Gary Chase, BSc, for invaluable assistance with the implementation of...
medication management, disease education, and assistance with implementation of lifestyle changes and medication barriers. The findings of our study are similar to studies in the current literature showing that pharmacist-led interventions, of varying models, improved HbA1c and adherence in patients with...
A 54-year-old female patient was referred by a physician to the pharmacist in a rural, integrated care team for a comprehensive medication review (CMR) to address the patient’s concerns of possible Parkinson’s disease (PD). While PD may occur over the progression of age, medications that...
Apply for the Novo Nordisk Patient Assistance Program (PAP) to see if you qualify to receive your Novo Nordisk diabetes medicine at no cost.
Management: Larger doses of lamotrigine may be needed when combined with estrogens. Specific dosing recommendations vary based on other concomitant medications and which medication is being initiated or discontinued. See interaction monograph for details. Consider therapy modification...
If FBG 4.0 mmol/L adjust insulin dose at clinician's discretion; cinsulin dose may be reduced (small increments of 2–4 U) in the presence of severe hypoglycemia (requiring assistance), or BLG 3.0 mmol/L in the preceding week. Do not increase insulin dose if fasting BGL 4.0 mmol/L any...